Evidence-Based Complementary and Alternative Medicine

Complementary and Alternative Therapies for Immune-Inflammation Interactions in the Digestive System


Publishing date
01 Aug 2021
Status
Closed
Submission deadline
09 Apr 2021

Lead Editor

1Beijing University of Chinese Medicine, Beijing, China

2Baruch S. Blumberg Institute, Doylestown, USA

3Kyung Hee University, Seoul, Republic of Korea

4Peking University, Beijing, China

This issue is now closed for submissions.
More articles will be published in the near future.

Complementary and Alternative Therapies for Immune-Inflammation Interactions in the Digestive System

This issue is now closed for submissions.
More articles will be published in the near future.

Description

Inflammation in the digestive system, a common local tissue reaction, usually originates from physical or chemical trauma, infection, or an abnormal immune response. Conversely, while digestive inflammation can enhance the reaction of the immune system, abnormal immune-inflammation interaction can lead to many diseases in the digestive system.

The challenge is that repeated inflammation and abnormal immune responses in the digestive system over time can evolve into cancer or tumours. Complementary and alternative medicine (CAM) - natural products and non-pharmacological therapies - might restore the balance between inflammation and immune response; however, we lack both strong evidence from clinical research and clear mechanisms from basic research.

This Special Issue aims to offer a translational science spectrum platform to discuss the laboratory findings, clinical insights, practice implications, and population health improvement of CAM in the immune-Inflammation interaction in the digestive system. In this way, we hope to bridge across the continuum of knowledge deployment, convert basic science discoveries to human application and clinical practice, disseminate the best practice into relevant communities, and ultimately modify the behaviour of whole populations to improve global wellness. Both original research articles and review articles are welcomed.

Potential topics include but are not limited to the following:

  • Chronic atrophic autoimmune gastritis
  • Virus hepatitis, including HBV and HCV
  • Primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH)
  • Autoimmune pancreatitis
  • Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD
  • Basic research, including in vivo and in vitro studies, pre-clinical research, epidemiological studies, and basic health services research
  • Translation to humans, including case studies, proof-of-concept studies, and phase I and II clinical trials
  • Translation to patients, including observational studies, phase III clinical trials, evidence synthesis, and clinical guideline development
  • Translation to practice, including phase IV clinical trials, health services research, and clinical outcomes research
  • Translation to population health, including population-level prevention and outcome studies, mass screening outcome studies, health policy studies, and social determinants of health

Articles

  • Special Issue
  • - Volume 2021
  • - Article ID 6629761
  • - Research Article

Uncovering the Mechanism of Curcuma in the Treatment of Ulcerative Colitis Based on Network Pharmacology, Molecular Docking Technology, and Experiment Verification

Suxian Liu | Qiaodong Li | ... | Jiang Lin
  • Special Issue
  • - Volume 2021
  • - Article ID 9962224
  • - Research Article

Acupuncture Regulates Serum Differentially Expressed Proteins in Patients with Chronic Atrophic Gastritis: A Quantitative iTRAQ Proteomics Study

Feng Li | Bai Yang | ... | Xiaomei Wang
  • Special Issue
  • - Volume 2021
  • - Article ID 9970240
  • - Research Article

Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology

Yan Jiang | Li Zhao | ... | Lihong Zhou
  • Special Issue
  • - Volume 2021
  • - Article ID 5548764
  • - Review Article

Tong Xie Yao Fang: A Classic Chinese Medicine Prescription with Potential for the Treatment of Ulcerative Colitis

Kai Chen | Yu Lou | Ying Zhu
  • Special Issue
  • - Volume 2021
  • - Article ID 6681903
  • - Research Article

Disrupted Resting-State Functional Connectivity between the Dorsal Attention, Default Mode, and Frontoparietal Networks in Nonorganic Gastrointestinal Disorder Patients with Spleen Deficiency Syndrome

Yanzhe Ning | Wenbin Jia | ... | Hongxiao Jia
  • Special Issue
  • - Volume 2021
  • - Article ID 6652858
  • - Research Article

Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients

Ting-Ting Jiang | Xiao-Li Liu | ... | Zhi-Yun Yang
  • Special Issue
  • - Volume 2021
  • - Article ID 6621368
  • - Review Article

Efficacy of Xuebijing Injection for Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Hongxin Chen | Zhaohui Bai | ... | Xingshun Qi
  • Special Issue
  • - Volume 2021
  • - Article ID 5525584
  • - Research Article

Essential Oils Derived from Momordica charantia Seeds Exhibited Antiulcer Activity against Hydrogen Chloride/Ethanol and Indomethacin

Nurul 'Ain Abu Bakar | Muhammad Nazrul Hakim Abdullah | ... | Yoke Keong Yong
  • Special Issue
  • - Volume 2021
  • - Article ID 6657141
  • - Research Article

Bu-Zhong-Yi-Qi Granule Enhances Colonic Tight Junction Integrity via TLR4/NF-κB/MLCK Signaling Pathway in Ulcerative Colitis Rats

Xiuhong Kang | Mengdi Jia | ... | Shengsheng Zhang
  • Special Issue
  • - Volume 2020
  • - Article ID 8899244
  • - Research Article

A Comprehensive Toxicological Assessment of Fulvic Acid

Chongshan Dai | Xilong Xiao | ... | Shusheng Tang
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate27%
Submission to final decision68 days
Acceptance to publication33 days
CiteScore3.000
Impact Factor2.629
 Submit

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.